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Abstract A polyclonal antibody (anti-PepTl/C) was raised fine, and the predicted protein, termed PepT1 [11], consists of 
against he rabbit intestinal H+-coupled oligopeptide transporter, 707 amino acids and has 12 membrane-spanning domains. On 
PepT1. Anti-PepTl/C detected 70-80-kDa protein in crude the basis of in vitro translation, the apparent molecular mass 
membranes obtained from rabbit duodenum, jejunum and ileum, of the product is 71 kDa. 
PepT1 was localized in the brush-border of the absorptive In the present study, we raised a polyclonal antibody 
epithelial cells by subcellular fractionation of membranes on a against a synthetic peptide corresponding to a fragment of 
sucrose density gradient and by immunohistochemistry using the deduced amino acid sequence of rabbit PepT1. Using 
light and electron microscopy. Transport activity for cephalo- this antibody, we determined the distribution of PepT1 pro- 
sporins and dipeptide expressed in Xenopus laevis oocytes tein between BBM and BLM in rabbit intestinal epithelial 
injected with total mRNA obtained from rabbit small intestine cells as an approach to clarify whether or not the peptide 
was eliminated completely by prehybridization of the mRNA transporters in the two membranes are identical. Oligopeptide 
with antisense oligonucleotide against the 5'-coding region of 
rabbit PepT1 cDNA. transporter is considered to have enormous potential as an 
oral drug delivery system, because this transporter mediates 
Key words." Peptide transport; [~-Lactam antibiotic; the intestinal absorption of not only oligopeptides, but also 
Intracellular localization; Basolateral membrane; peptidomimetic drugs including orally active [Mactam 
Xenopus oocyte; Hybrid depletion antibiotics [8,25,26]. So, the ability of PepT1 to transport 
orally active [Mactam antibiotics was also examined by ex- 
pression of the mRNA in Xenopus oocytes. 
1. Introduction 
2. Materials and methods 
Intestinal transport of oligopeptides generated by digestion 
of dietary protein involves two distinctive transcellular mem- 2.1. Preparation of anti-PepT1 polyclonal antibody 
brane transport processes: entry into the enterocyte across the Rabbit anti-PepT1 polyclonal antibody (anti-PepT1/C) was raised 
against a synthetic peptide (CYPSLAPVSQTQM) corresponding to
brush-border membrane (BBM) and discharge to the blood- the deduced C-terminal amino acid sequence ofPepT1 [11]. The pep- 
stream across the basolateral membrane (BLM). A compre- tide was conjugated tokeyhole limpet hemocyanin (Sigma, St. Louis, 
hensive description of intestinal bsorption requires character- MO, USA), emulsified inan equal volume of Freund's adjuvant (Dif- 
ization of the transport systems in both the brush-border and co, Detroit, MI, USA), and injected subcutaneously into New Zea- 
land White rabbits. 
the basolateral membranes of epithelial cells. Previous tudies 
of oligopeptide transporter(s) in the small intestine have been 2.2. Subeellularfractionation 
restricted exclusively to functional characterization f trans- Separation of BBM and BLM was achieved by a modification of 
port activities of BBM vesicles [1 8]. However, the presence of the method of Knickelbein [18]. The mucosal scrapings from the 
a basolateral peptide transport activity has also recently been proximal 1.2 m of small intestine of a fasted rabbit (Japanese White, 
male, 2.5 kg body weight) were homogenized in sucrose buffer (250 
demonstrated byusing a BLM vesicle preparation [9]. Saito et mM sucrose, 12 mM 2-amino-2-hydroxymethyl-l,3-propanediol 
al. also examined the basolateral-to-apical tr nscellular trans- (Tris), 16 mM 2-[4-(2-hydroxyethyl)-l-piperazinyl]ethanesulfonic acid 
port in an intestinal epithelial cell line, Caco-2, and suggested (HEPES), 1mM ethylenediamine-N,N,N',N'-tetraacetic cid (EDTA), 
the existence of a basolateral dipeptide transporter [10]. How- and 0.1 mM phenylmethanesulfonyl fluoride (PMSF)), and crude 
membranes were prepared by successive c ntrifugation at 3000 xg 
ever, no evidence for a possible identity of BBM and BLM for 10 min and 41000×g for 30 min. The resulting pellet was sus- 
peptide transporters at the molecular level is available, so it pended in 60% sucrose, and was layered at the bottom of a 28~[8% 
remains to be seen whether the transport activities in the two continuous sucrose gradient, hen centrifuged at111 700 × g for 3.5 h. 
membranes are expressed by the same protein. Ten fractions of similar volume were collected and used for enzyme 
Recently, cDNA clones encoding an H+-coupled peptide assays and immunoblotting. 
transporter have been isolated from intestine or kidney of 2.3. Enzyme assays 
rabbits, humans and rats [11-16], including a report from Alkaline phosphatase and Na+/K+-ATPase were assayed as de- 
our laboratory [17]. The first report concerned rabbit intes- scribed by Pekarthy et al. [19] and Scharscbmidt e  al. [20], respec- 
tively. 
*Corresponding author. Fax: (81) (762) 34-4477. 2.4. Immunoblotting 
Membrane proteins were separated by 10% SDS-polyacrylamide-gel 
Abbreviations." BBM, brush-border membrane; BLM, basolateral electrophoresis, followed by transfer to PVDF membrane (Millipore, 
membrane Bedford, MA, USA). The blot was immunostained with anti-PepTl/C 
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Table 1 
Hybrid depletion of rabbit intestinal mRNA-induced uptake of substrates by Xenopus laevis oocytes with PepT1 antisense oligonucleotide 
Substrate Uptake (pmol/h/oocyte) 
Water-injected mRNA-injected 
Control +Sense +Antisense 
[14C]GlySar 0.63 + 0.07* 4.53 4 0.18 5.79 + 0.63 1.25 _+ 0.13* 
Ceftibuten 0.89 + 0.25* 54.16 + 11.86 56.40 + 5.33 0.99 + 0.47* 
Cefadroxil 0.07 + 0.04* 107.55 + 16.48 100.36 + 16.88 4.99 + 3.12" 
[ZH]Leucine 3.29 + 0.18* 9.10 + 0.72 7.54 + 1.13 9.10 + 1.22 
Oocytes were injected with 50-nl aliquots of rabbit intestinal total mRNA (25 ng) or water. Prior to injection, total mRNA was incubated with 
PepT1 sense or antisense oligonucleotide (0.25 ng) as described in Section 2. Uptake of [t4C]glycylsarcosine (50 ~tM), ceftibuten (2 mM), cefadroxil 
(2 mM) and [aH]L-leucine (50 nM) was measured at 25°C at pH 5.5. Each datum represents the mean + S.E.M. of 5 9 determinations. 
*Significantly different (P < 0.05) from the mRNA-injected control value by Student's t-test. 
and developed with the BICP/NBT phosphatase substrate system 3. Results and discussion 
(Kirkegaard and Perry Lab., Gaithersburg, MD, USA). 
2.5. Immunohistochemistry 3.1. Hybrid depletion of  intestinal oligopeptide transporter 
Rabbits were fixed by transcardial perfusion with 4% paraformal- using antisense oligonucleotide 
dehyde and portions of the intestine were dissected out as described The pharmacological relevance of PepT1 in the intestinal 
by Amano et al. [21]. For light microscopic immunohistochemistry, absorption of peptidomimetic 13-1actam antibiotics was evalu- 
the cryoprotected tissue blocks were frozen and sectioned on a cryo- 
stat. Following successive pretreatments with 0.3% Tween 20 in phos- ated by measuring the transport activity of Xenopus laevis 
phate-buffered saline (PBS), 0.3% H202 in methanol and 5% normal oocytes injected with total mRNAs obtained from rabbit in- 
porcine serum, the sections were incubated with anti-PepT1/C serum, testinal epithelial cells in the presence of an inwardly directed 
They were washed with PBS, and the immunoreaction was visualized H+-gradient (Table 1). An antisense oligonucleotide against 
by incubating the sections successively with biotinylated anti-rabbit the 5'-coding region of the PepT1 cDNA clone effectively 
IgG (Dakopatts, Glostrup, Denmark), streptavidin-conjugated horse- 
eliminated uptake of the dipeptide [14C]glycylsarcosine, while radish peroxidase (HRP) (Dakopatts), and Y,Y-diaminobenzidine tet- 
rahydrochloride (DAB) in the presence of 0.01% hydrogen peroxide, a sense oligonucleotide was without effect. These oligonucleo- 
Nuclei were counter-stained with methyl green, tides hardly affected the uptake of leucine, proving the speci- 
For immuno-electron microscopic analysis, the sections prepared ficity of hybrid depletion of the oligopeptide transporter. This 
for light-microscopic immunohistochemistry were postfixed with 
antisense oligonucleotide virtually eliminated uptake of the 0.5% OsO4. After block-staining with uranyl acetate, the sections 
were dehydrated in graded ethanols, embedded in Epon 812, and two 13-1actam antibiotics, ceftibuten and cefadroxil, suggesting 
cut into ultrathin sections, that these 13-1actam antibiotics are almost exclusively trans- 
ported via PepT1 in intestinal epithelium. Therefore, PepT1 
2.6. Transport studies is suggested to be the major participant in intestinal absorp- 
Xenopus laevis oocytes were injected with total mRNAs extracted 
from rabbit small intestine as described previously [22,23]. Transport tion of many peptidomimetic drugs. 
activity was measured in buffer containing 2 mM 13-1actam antibiotics 
(ceftibuten or cefadroxil), 50 pM [14C]glycylsarcosine or 50 nM 
[3H]leucine at 25°C. 13-Lactam antibiotics and radioactive compounds A 
taken up by oocytes were analyzed by HPLC and with a liquid scin- 2- • 4 
tillation counter, respectively. For the hybrid depletion study, total ~ 
mRNAs were prehybridized with sense or antisense oligonucleotide ~ 3 
corresponding to the 5'-coding region of rabbit PepT1 cDNA, and ~ =, 
then injected into oocytes. ~!  ~" 
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Fig. 2. Distribution of PepT1 protein between brush-border and ba- 
Fig. 1. Western blot analysis of total membranes from rabbit large solateral membranes. Crude membrane fraction obtained from rab- 
and small intestine. Total membrane proteins (25 ~tg/lane) from the bit jejunum was separated on a 28-48% continuous ucrose density 
duodenum (lane 1), jejunum (lane 2), ileum (lane 3) and colon (lane gradient. Ten fractions of similar volume were collected and ana- 
4) were subjected to 10% SDS-polyacrylamide-gel electrophoresis lyzed for the indicated marker enzymes (A) and subjected to Wes- 
followed by transfer to PVDF membrane. The blot was immuno- tern blotting with anti-PepTl/C antiserum (B) as described in Sec- 
stained with anti-PepT1/C antiserum (A) or preimmune serum (B). tion 2. 
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Fig. 3. Immunohistochemical localization of PepT1 in rabbit jejunum. Frozen sections were stained with anti-PepT1/C antiserum in the absence 
(A) or presence of 4 ~tM peptide antigen (B), and detected with horseradish peroxidase and DAB (brown). Both sections were counter-stained 
for nuclei with methyl green (green). 
3.2. Intestinal distribution of PepT1 in rabbit cDNA as a probe. They found PepT1 mRNA in intestine, 
A polyclonal antibody (anti-PepTl/C) was raised against a kidney and liver. The abundance of PepT1 protein in duode- 
synthetic peptide corresponding to the carboxy-terminal resi- num, jejunum and ileum (Fig. 1) is consistent with these seg- 
dues 696-707 of the predicted PepT1 protein. Immunoblotting ments being the principal sites of intestinal absorption of di- 
using anti-PepTl/C was carried out with total membrane frac- gestion products, but we failed to detect PepT1 protein in liver 
tions obtained from mucosa of large and small intestine. Fig. and kidney (data not shown). It is possible that multiple pep- 
1 shows that anti-PepT1/C, but not preimmune serum, recog- tide transporters modified in the carboxy-terminus exist in 
nized a 70-80-kDa protein in the total membrane fraction such tissues. To solve this problem, a hybrid depletion study 
obtained from duodenum, jejunum and ileum. To confirm using antisense oligonucleotide against he C-terminal region 
the specificity of this immunostaining, the blots were incu- should be effective. 
bated with anti-PepTl/C in the presence of the peptide anti- 
gen that had been used to generate the anti-PepTl/C or in the 3.3. Distribution of PepT1 between brush-border and 
presence of irrelevant mouse anion-exchanger (band III) pep- basolateral membranes 
tide (CTFSKLIKIFQDY) [24]. The antigen peptide elimi- To examine the distribution of PepT1 between BBM and 
nated the staining of 70 80-kDa protein, while the irrelevant BLM, a crude membrane preparation was fractionated on a 
peptide was without effect (data not shown). 28-48% continuous ucrose density gradient. Alkaline phos- 
The apparent molecular mass of PepT1 protein detected in phatase and Na+/K+-ATPase were used as brush-border and 
total membranes obtained from duodenum, jejunum and basolateral enzyme markers, respectively, and good separation 
ileum was in the range of 70-80 kDa. This value is consistent of the membranes was confirmed (Fig. 2A). In this prepara- 
with that of an in vitro translation product (ca. 71 kDa) and tion, PepT1 protein was distributed to the bottom fraction, 
also with that of the deduced amino acid sequence of 707 and its distribution profile showed good correspondence to
amino acids (,~79 kDa) with N-glycosylation (~ 11 kDa) that of alkaline phosphatase activity, the BBM marker 
[11]. The small difference in size presumably represents the (Fig. 2B). 
post-translational modification or degradation of PepT1 pro- 
tein in vivo. Fei et al. [11] studied the tissue distribution of 3.4. Light microscopical localization of  PepT1 
PepT1 by Northern hybridization using full-length PepT1 In the small intestine, immunoreactivity for PepT1 was lo- 
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A testinal epithelial cells at the molecular level. Further, it is 
established that the basolateral o igopeptide transporter is dis- 
tinct from PepT1, at least in its carboxy-terminal immuno- 
reactivity. 
In conclusion, PepT1 is considered to play a key role in 
intestinal absorption of orally active [3-1actam antibiotics 
and other peptidomimetic drugs, especially in their passage 
across the brush-border membrane into the epithelial cells. 
Although PepT1 was localized in the brush-border mem- 
branes of rabbit intestine, Dyer et al. demonstrated the pres- 
ence of a basolateral peptide transport activity [9]. This im- 
plies the existence of another peptide transporter on the 
basolateral membrane, although the possibility is not com- 
B pletely excluded that their results were due to brush-border 
membrane contamination. To clarify this problem, further 
studies including molecular identification of the basolateral 
transporter molecule are required. 
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